合成肽CK2.3提高老年小鼠骨密度

Journal of bone research Pub Date : 2018-01-01 Epub Date: 2018-06-30 DOI:10.4172/2572-4916.1000190
John Nguyen, Hilary Weidner, Lora M Schell, Linda Sequeira, Ryan Kabrick, Saurabh Dharmadhikari, Harold Coombs, Randall L Duncan, Liyun Wang, Anja Nohe
{"title":"合成肽CK2.3提高老年小鼠骨密度","authors":"John Nguyen,&nbsp;Hilary Weidner,&nbsp;Lora M Schell,&nbsp;Linda Sequeira,&nbsp;Ryan Kabrick,&nbsp;Saurabh Dharmadhikari,&nbsp;Harold Coombs,&nbsp;Randall L Duncan,&nbsp;Liyun Wang,&nbsp;Anja Nohe","doi":"10.4172/2572-4916.1000190","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Osteoporosis is a silent disease caused by low bone mineral density that results in bone fractures in 1 out of 2 women and 1 in 4 men over the age of 50. Although several treatments for osteopenia and osteoporosis are available, they have severe side effects and new treatments are desperately needed. Current treatments usually target osteoclasts and inhibit their activity or differentiation. Treatments that decrease osteoclast differentiation and activity but enhance osteogenesis and osteoblast activity are not available. We recently developed a peptide, CK2.3, that induces bone formation and increases bone mineral density as demonstrated by injection over the calvaria of 6 to 9-day-old mice and tail vein injection of 8-week-old mice. CK2.3 also decreased osteoclast formation and activity. However, these studies raise questions: does CK2.3 induce similar results in old mice and if so, what is the effective CK2.3 concentration and, is the bone mineral density of vertebrae of the spinal column increased as well?</p><p><strong>Methods: </strong>CK2.3 was systematically injected into the tail vein of female 6-month old mice with various concentrations of CK2.3: 0.76 μg/kg, 2.3 μg/kg, or 6.9 μg/kg per mice. Mice were sacrificed one week, two weeks, and four weeks after the first injection. Their spines and femurs were collected and analyzed for bone formation.</p><p><strong>Results: </strong>Femur and lumbar spine analyses found increased bone mineral density (BMD) and mineral apposition rate, with greater stiffness observed in femoral samples four weeks after the first injection. Histochemistry showed that osteoclastogenesis was suppressed in CK2.3 treated senile mice.</p><p><strong>Conclusions: </strong>For the first time, this study showed the increase of lumbar spine BMD by CK2.3. Moreover, it showed that enhancement of femur BMD was accompanied by increased femur stiffness only at medium concentration of CK2.3 four weeks after the first injection indicating the maintenance of bone's structural integrity by CK2.3.</p>","PeriodicalId":73628,"journal":{"name":"Journal of bone research","volume":"6 2","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2018-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.4172/2572-4916.1000190","citationCount":"8","resultStr":"{\"title\":\"Synthetic Peptide CK2.3 Enhances Bone Mineral Density in Senile Mice.\",\"authors\":\"John Nguyen,&nbsp;Hilary Weidner,&nbsp;Lora M Schell,&nbsp;Linda Sequeira,&nbsp;Ryan Kabrick,&nbsp;Saurabh Dharmadhikari,&nbsp;Harold Coombs,&nbsp;Randall L Duncan,&nbsp;Liyun Wang,&nbsp;Anja Nohe\",\"doi\":\"10.4172/2572-4916.1000190\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Background: </strong>Osteoporosis is a silent disease caused by low bone mineral density that results in bone fractures in 1 out of 2 women and 1 in 4 men over the age of 50. Although several treatments for osteopenia and osteoporosis are available, they have severe side effects and new treatments are desperately needed. Current treatments usually target osteoclasts and inhibit their activity or differentiation. Treatments that decrease osteoclast differentiation and activity but enhance osteogenesis and osteoblast activity are not available. We recently developed a peptide, CK2.3, that induces bone formation and increases bone mineral density as demonstrated by injection over the calvaria of 6 to 9-day-old mice and tail vein injection of 8-week-old mice. CK2.3 also decreased osteoclast formation and activity. However, these studies raise questions: does CK2.3 induce similar results in old mice and if so, what is the effective CK2.3 concentration and, is the bone mineral density of vertebrae of the spinal column increased as well?</p><p><strong>Methods: </strong>CK2.3 was systematically injected into the tail vein of female 6-month old mice with various concentrations of CK2.3: 0.76 μg/kg, 2.3 μg/kg, or 6.9 μg/kg per mice. Mice were sacrificed one week, two weeks, and four weeks after the first injection. Their spines and femurs were collected and analyzed for bone formation.</p><p><strong>Results: </strong>Femur and lumbar spine analyses found increased bone mineral density (BMD) and mineral apposition rate, with greater stiffness observed in femoral samples four weeks after the first injection. Histochemistry showed that osteoclastogenesis was suppressed in CK2.3 treated senile mice.</p><p><strong>Conclusions: </strong>For the first time, this study showed the increase of lumbar spine BMD by CK2.3. Moreover, it showed that enhancement of femur BMD was accompanied by increased femur stiffness only at medium concentration of CK2.3 four weeks after the first injection indicating the maintenance of bone's structural integrity by CK2.3.</p>\",\"PeriodicalId\":73628,\"journal\":{\"name\":\"Journal of bone research\",\"volume\":\"6 2\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2018-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.4172/2572-4916.1000190\",\"citationCount\":\"8\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Journal of bone research\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.4172/2572-4916.1000190\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2018/6/30 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of bone research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.4172/2572-4916.1000190","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2018/6/30 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 8

摘要

背景:骨质疏松症是一种由低骨密度引起的无声疾病,在50岁以上的人群中,1 / 2的女性和1 / 4的男性会发生骨折。虽然有几种治疗骨质减少和骨质疏松的方法,但它们都有严重的副作用,迫切需要新的治疗方法。目前的治疗通常针对破骨细胞并抑制其活性或分化。减少破骨细胞分化和活性但增强成骨细胞和成骨细胞活性的治疗方法尚不存在。我们最近开发了一种肽,CK2.3,可以诱导骨形成并增加骨矿物质密度,通过6至9日龄小鼠的颅骨注射和8周龄小鼠的尾静脉注射证明了这一点。CK2.3还能降低破骨细胞的形成和活性。然而,这些研究提出了一个问题:CK2.3是否会在老年小鼠中引起类似的结果,如果是,CK2.3的有效浓度是多少,脊柱椎骨的骨矿物质密度是否也会增加?方法:将CK2.3以不同浓度(0.76 μg/kg、2.3 μg/kg、6.9 μg/kg)系统注射至雌性6月龄小鼠尾静脉。小鼠在第一次注射后1周、2周和4周被处死。收集其脊柱和股骨,分析其骨形成情况。结果:股骨和腰椎分析发现,第一次注射后四周,股骨样本的骨矿物质密度(BMD)和矿物质附着率增加,硬度增加。组织化学表明,CK2.3处理的老年小鼠破骨细胞生成受到抑制。结论:本研究首次显示CK2.3对腰椎骨密度的增加。此外,研究表明,在第一次注射后4周,仅在中等浓度的CK2.3下,股骨骨密度的增强伴随着股骨刚度的增加,这表明CK2.3维持了骨的结构完整性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

Synthetic Peptide CK2.3 Enhances Bone Mineral Density in Senile Mice.

Synthetic Peptide CK2.3 Enhances Bone Mineral Density in Senile Mice.

Synthetic Peptide CK2.3 Enhances Bone Mineral Density in Senile Mice.

Synthetic Peptide CK2.3 Enhances Bone Mineral Density in Senile Mice.

Background: Osteoporosis is a silent disease caused by low bone mineral density that results in bone fractures in 1 out of 2 women and 1 in 4 men over the age of 50. Although several treatments for osteopenia and osteoporosis are available, they have severe side effects and new treatments are desperately needed. Current treatments usually target osteoclasts and inhibit their activity or differentiation. Treatments that decrease osteoclast differentiation and activity but enhance osteogenesis and osteoblast activity are not available. We recently developed a peptide, CK2.3, that induces bone formation and increases bone mineral density as demonstrated by injection over the calvaria of 6 to 9-day-old mice and tail vein injection of 8-week-old mice. CK2.3 also decreased osteoclast formation and activity. However, these studies raise questions: does CK2.3 induce similar results in old mice and if so, what is the effective CK2.3 concentration and, is the bone mineral density of vertebrae of the spinal column increased as well?

Methods: CK2.3 was systematically injected into the tail vein of female 6-month old mice with various concentrations of CK2.3: 0.76 μg/kg, 2.3 μg/kg, or 6.9 μg/kg per mice. Mice were sacrificed one week, two weeks, and four weeks after the first injection. Their spines and femurs were collected and analyzed for bone formation.

Results: Femur and lumbar spine analyses found increased bone mineral density (BMD) and mineral apposition rate, with greater stiffness observed in femoral samples four weeks after the first injection. Histochemistry showed that osteoclastogenesis was suppressed in CK2.3 treated senile mice.

Conclusions: For the first time, this study showed the increase of lumbar spine BMD by CK2.3. Moreover, it showed that enhancement of femur BMD was accompanied by increased femur stiffness only at medium concentration of CK2.3 four weeks after the first injection indicating the maintenance of bone's structural integrity by CK2.3.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信